Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer
Saved in:
| Published in: | Journal of Experimental Pharmacology |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868552905431187456 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Journal of Experimental Pharmacology |
| description | |
| discipline_display | Laboratory and Experimental Medicine |
| discipline_facet | Laboratory and Experimental Medicine |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:67013 |
| institution | FRELIP |
| journal_source_facet | Journal of Experimental Pharmacology |
| last_indexed | 2026-06-20T21:28:31.257Z |
| publishDate | 2025 |
| publishDateSort | 2025 |
| record_format | rss_article |
| spellingShingle | In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer Laboratory and Experimental Medicine General Laboratory and Experimental Medicine |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Laboratory and Experimental Medicine General Laboratory and Experimental Medicine |
| subject_facet | Laboratory and Experimental Medicine General Laboratory and Experimental Medicine |
| title | In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer |
| title_alt | Inhibición terapéutica in vivo del regulador de glucólisis y apoptosis inducido por Tp53 (TIGAR) mediante administración intravenosa de un siRNA-biopolímero anti-oncológico, TI6752 (Tituxistatina), en un modelo preclínico de xenoinjerto de cáncer colorrectal Inhibition thérapeutique in vivo du régulateur de la glycolyse et de l'apoptose induit par Tp53 (TIGAR) par administration intraveineuse d'un siRNA-biopolymère anti-oncologique, TI6752 (Tituxistatine), dans un modèle de xénogreffe préclinique de cancer colorectal Inibição Terapêutica in vivo do Regulador da Glicólise e Apoptose Induzido por Tp53 (TIGAR) por Administração Intravenosa de um siRNA-Biopolímero Antioncológico, TI6752 (Tituxistatina), em um Modelo Pré-Clínico de Xenoenxerto de Câncer Colorretal |
| title_auth | In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer |
| title_es_txt | Inhibición terapéutica in vivo del regulador de glucólisis y apoptosis inducido por Tp53 (TIGAR) mediante administración intravenosa de un siRNA-biopolímero anti-oncológico, TI6752 (Tituxistatina), en un modelo preclínico de xenoinjerto de cáncer colorrectal |
| title_fr_txt | Inhibition thérapeutique in vivo du régulateur de la glycolyse et de l'apoptose induit par Tp53 (TIGAR) par administration intraveineuse d'un siRNA-biopolymère anti-oncologique, TI6752 (Tituxistatine), dans un modèle de xénogreffe préclinique de cancer colorectal |
| title_full | In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer |
| title_fullStr | In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer |
| title_full_unstemmed | In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer |
| title_pt_txt | Inibição Terapêutica in vivo do Regulador da Glicólise e Apoptose Induzido por Tp53 (TIGAR) por Administração Intravenosa de um siRNA-Biopolímero Antioncológico, TI6752 (Tituxistatina), em um Modelo Pré-Clínico de Xenoenxerto de Câncer Colorretal |
| title_short | In vivo Therapeutic Inhibition of the Tp53-Induced Glycolysis and Apoptosis Regulator (TIGAR) by Intravenous Administration of an Anti-Oncological siRNA-Biopolymer, TI6752 (Tituxistatin), in a Preclinical Xenograft Model of Colorectal Cancer |
| title_sort | in vivo therapeutic inhibition of the tp53-induced glycolysis and apoptosis regulator (tigar) by intravenous administration of an anti-oncological sirna-biopolymer, ti6752 (tituxistatin), in a preclinical xenograft model of colorectal cancer |
| topic | Laboratory and Experimental Medicine General Laboratory and Experimental Medicine |
| url | https://www.dovepress.com/in-vivo-therapeutic-inhibition-of-the-tp53-induced-glycolysis-and-apop-peer-reviewed-fulltext-article-JEP |